رفتن به محتوا

تداخل‌های دارویی

Avapritinib + Imatinib

شدت: شدید

Avapritinib and Imatinib: major interaction.

آخرین به‌روزرسانی

ویژه کادر درمان — فقط جهت مرجع. این صفحه خلاصه‌ای کوتاه است، توصیه پزشکی نیست و جایگزین بروشور رسمی یا قضاوت بالینی نمی‌شود. پیش از تجویز یا تحویل دارو همیشه بررسی کنید.

محتوای بالینی این صفحه فقط به زبان انگلیسی موجود است.

خلاصه

Avapritinib is a CYP3A4 substrate, and imatinib is a moderate CYP3A4 inhibitor. Avapritinib exposure may increase, raising risks of cognitive effects, intracranial hemorrhage and edema. Both are kinase inhibitors, and imatinib is also used in GIST, where combination is not typical.

معنای این تداخل به زبان ساده

Avapritinib and Imatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Avapritinib belongs to Oncology; Imatinib belongs to Oncology.

سطح شواهد: Moderate

چرا رخ می‌دهد

CYP3A4 inhibition by imatinib reduces avapritinib clearance.

اقدام لازم

Avoid the combination if possible. If necessary, use the reduced avapritinib starting dose from labeling and monitor for cognitive effects and bleeding.

از داروساز چه بپرسید

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

ویژه اعضای Pro+

باز کردن کل صفحه

یک حساب بسازید و دوره آزمایشی Pro+ را شروع کنید تا توصیه‌های کامل مدیریت Avapritinib و Imatinib، یادداشت‌های تکمیلی، جزئیات شواهد و بررسی‌کننده تداخل برای کل نسخه را باز کنید.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Pro+ را ۱۴ روز رایگان در وب امتحان کنید. بدون نیاز به کارت.

پرسش‌های متداول

Can I take Avapritinib with Imatinib?

MediHelp rates the interaction as major. Avapritinib and Imatinib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Avapritinib is a CYP3A4 substrate, and imatinib is a moderate CYP3A4 inhibitor. Avapritinib exposure may increase, raising risks of cognitive effects, intracranial hemorrhage and edema. Both are kinase inhibitors, and imatinib is also used in GIST, where combination is not typical.

How serious is the interaction between Avapritinib and Imatinib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If necessary, use the reduced avapritinib starting dose from labeling and monitor for cognitive effects and bleeding.

What other medicines interact with Imatinib?

MediHelp also lists interactions of Imatinib with, for example, Lomitapide, Lonafarnib, Amobarbital. The full list is on the Imatinib page.

تک‌نگاری کامل، دوزاژ و بررسی تداخل دارویی در برنامه MediHelp

مرجع کامل را باز کنید، تداخل چند دارو را بررسی کنید و از ابزارهای دوز در برنامه MediHelp استفاده کنید.

مرور از A تا Z · تداخل‌های دارویی

دریافت برنامه ورود